Belite Bio (BLTE) Analyst & Key Data

Analyst Consensus

Buy18 analysts

Buy

Updated Sep 12, 2026

Total Analysts18

Buy

6

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$173.79

Median Target+22.31%

$212.56

Potential upside vs current price

DCF Value-93.94%

$10.53

Potential downside vs current price

Current Stock Price

$173.79

Median Target+22.31%

$212.56

Potential upside vs current price

DCF Value-93.94%

$10.53

Potential downside vs current price

Analyst Consensus

Buy18 analysts

Buy

Updated Sep 12, 2026

Total Analysts18

Buy

6

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$173.79

Median Target+22.31%

$212.56

Potential upside vs current price

DCF Value-93.94%

$10.53

Potential downside vs current price

Current Stock Price

$173.79

Median Target+22.31%

$212.56

Potential upside vs current price

DCF Value-93.94%

$10.53

Potential downside vs current price

Belite Bio, Inc